These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Schnabel A; Reuter M; Biederer J; Richter C; Gross WL Semin Arthritis Rheum; 2003 Apr; 32(5):273-84. PubMed ID: 12701038 [TBL] [Abstract][Full Text] [Related]
3. [Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease]. Marie I; Dominique S Presse Med; 2006 Apr; 35(4 Pt 2):683-95. PubMed ID: 16614615 [TBL] [Abstract][Full Text] [Related]
4. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Yamasaki Y; Yamada H; Yamasaki M; Ohkubo M; Azuma K; Matsuoka S; Kurihara Y; Osada H; Satoh M; Ozaki S Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626 [TBL] [Abstract][Full Text] [Related]
5. [Interstitial lung diseases in polymyositis and dermatomyositis]. Marie I; Dominique S; Rémy-Jardin M; Hatron PY; Hachulla E Rev Med Interne; 2001 Nov; 22(11):1083-96. PubMed ID: 11817120 [TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease in polymyositis and dermatomyositis. Hirakata M; Nagai S Curr Opin Rheumatol; 2000 Nov; 12(6):501-8. PubMed ID: 11092199 [TBL] [Abstract][Full Text] [Related]
7. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis. Tanaka F; Origuchi T; Migita K; Tominaga M; Kawakami A; Kawabe Y; Eguchi K Intern Med; 2000 May; 39(5):428-30. PubMed ID: 10830189 [TBL] [Abstract][Full Text] [Related]
8. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases]. Bartosiewicz M; Siemion-Szcześniak I; Sobiecka M; Wyrostkiewicz D; Radwan-Röhrenschef P; Lewandowska K; Langfort R; Oniszh K; Franczuk M; Kuś J Pneumonol Alergol Pol; 2013; 81(6):556-66. PubMed ID: 24142786 [TBL] [Abstract][Full Text] [Related]
9. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940 [TBL] [Abstract][Full Text] [Related]
10. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726 [TBL] [Abstract][Full Text] [Related]
11. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970 [TBL] [Abstract][Full Text] [Related]
12. [Interstitial lung disease in polymyositis/dermatomyositis]. Schnabel A Z Rheumatol; 2013 Apr; 72(3):220-6. PubMed ID: 23553021 [TBL] [Abstract][Full Text] [Related]
13. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis. Shimojima Y; Ishii W; Matsuda M; Kishida D; Ikeda SI J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510 [TBL] [Abstract][Full Text] [Related]
14. Chronological evaluation of the onset of histologically confirmed interstitial pneumonia associated with polymyositis/dermatomyositis. Yang Y; Fujita J; Tokuda M; Bandoh S; Ishida T Intern Med; 2002 Dec; 41(12):1135-41. PubMed ID: 12521202 [TBL] [Abstract][Full Text] [Related]
15. Biologics in polymyositis and dermatomyositis-associated interstitial lung disease. Sun Y; He Y; Liu Y; Shi G Curr Pharm Biotechnol; 2014; 15(6):521-4. PubMed ID: 25213360 [TBL] [Abstract][Full Text] [Related]
16. Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide. Meyer O; Hayem G; Palazzo E; Crestani B; Debray MP; Ballard M Clin Exp Rheumatol; 2005; 23(5):724. PubMed ID: 16173257 [No Abstract] [Full Text] [Related]
17. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis. Yoshida T; Koga H; Saitoh F; Sakamoto M; Harada M; Yoshida H; Sakisaka S; Sata M Intern Med; 1999 Sep; 38(9):733-8. PubMed ID: 10480306 [TBL] [Abstract][Full Text] [Related]
18. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis]. Saku N; Ohno S; Sugiyama Y; Kitamura S Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):585-9. PubMed ID: 9805908 [TBL] [Abstract][Full Text] [Related]
20. Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis. Yamanaka Y; Baba T; Hagiwara E; Yanagawa N; Takemura T; Nagaoka S; Sakai F; Kuwano K; Ogura T Eur J Radiol; 2018 Oct; 107():26-32. PubMed ID: 30292269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]